Cardiogram is a digital health company announced that it's wearable-based monitoring for atrial fibrillation and diabetes is now covered by Oscar Health Insurance, without paying out of pocket. The coverage will help provide end-to-end preventive care: continuous wearable monitoring, convenient testing, contextualized results, and clinical triage.Impact of Chronic ConditionsFor chronic conditions like diabetes, atrial fibrillation, hypertension, and sleep apnea, anywhere between 20–80% of cases
Read More
5 Groundbreaking Findings from the Stanford and Apple Heart Study
Stanford Medicine researchers recently released preliminary results of the Apple Heart Study, the largest study ever of its kind, which enrolled over 400,000 participants from all 50 states in a span of only eight months.
Apple Heart Study Overview
Presented at American College of Cardiology’s 68th Annual Scientific Session and Expo in New Orleans, the study was launched in 2017 to evaluate Apple Watch’s irregular rhythm notification, which occasionally checks the heart's rhythm in the
Read More
Apple, Stanford Launches Heart Study App to Identify Irregular Heart Rhythms
Apple in partnership with Stanford Medicine has announced the launch of the Apple Heart Study app, a first-of-its-kind innovative research study using Apple Watch’s heart rate sensor to collect data on irregular heart rhythms and notify users who may be experiencing atrial fibrillation (AFib). The Apple Heart Study app uses this technology to identify an irregular heart rhythm.Atrial Fibrillation (AFib), is the most common heart arrhythmia, and a leading cause of stroke. AFib affects more than
Read More
Medical Device Company BioSig Lands 10-Year with Strategic Partnership with Mayo Clinic
Medical device company BioSig has inked a 10-year strategic partnership with Mayo Clinic and Mayo Clinic Ventures. The expanded par expanded collaboration with Mayo builds upon the work realized under the Advanced Clinical Research Program that was signed with Mayo Clinic in March 2016.Partnership DetailsAs part of 10-year agreement, BioSig and Mayo will be developing advanced clinical features and applications for the company’s PURE EP System, which is addressing an unmet technology need for
Read More
